Literature DB >> 23323778

Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference.

Jennifer Walsh1, Simon Mills.   

Abstract

The fourth annual European Paediatric Formulation Initiative (EuPFI) conference on Formulating Better Medicines for Children was held on 19-20 September 2012 at the Institute of Molecular Genetics Congress Centre, Prague, Czech Republic. The 2-day conference concentrated on the latest advances, challenges and opportunities for developing medicinal products and administration devices for pediatric use, both from European and US perspectives. It was aimed specifically at providing exposure to emerging practical applications, and for illustrating remedies utilized by pediatric drug-development teams to overcome hurdles faced in developing medicines for pediatric patients. The conference format included plenary talks, focus sessions on each of the EuPFI work streams (extemporaneous preparations, excipients, pediatric administration devices, taste masking and taste assessment, age-appropriate formulations), case studies, soapbox sessions and a parallel poster display. This conference report summarizes the keynote lectures and also gives a flavor of other presentations and posters from the conference.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23323778     DOI: 10.4155/tde.12.135

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  6 in total

1.  Pharmacovigilance for children's sake.

Authors:  Kristina Star; I Ralph Edwards
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 2.  Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations.

Authors:  Anteneh Belayneh; Ebisa Tadese; Fantahun Molla
Journal:  Int J Gen Med       Date:  2020-11-09

3.  Solid oral forms availability in children: a cost saving investigation.

Authors:  Audrey Lajoinie; Emilie Henin; Behrouz Kassai; David Terry
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.

Authors:  Yi-Dan Chen; Zhong-Yuan Liang; Yan-Yan Cen; He Zhang; Mei-Gui Han; Yun-Qiao Tian; Jie Zhang; Shu-Jun Li; Da-Sheng Yang
Journal:  Drug Des Devel Ther       Date:  2015-11-20       Impact factor: 4.162

5.  Adverse drug reactions in hospitalized Colombian children.

Authors:  Roxana de Las Salas; Daniela Díaz-Agudelo; Francisco Javier Burgos-Flórez; Claudia Vaca; Dolores Vanessa Serrano-Meriño
Journal:  Colomb Med (Cali)       Date:  2016-09-30

Review 6.  Excipients in the Paediatric Population: A Review.

Authors:  Khadija Rouaz; Blanca Chiclana-Rodríguez; Anna Nardi-Ricart; Marc Suñé-Pou; Dèbora Mercadé-Frutos; Josep María Suñé-Negre; Pilar Pérez-Lozano; Encarna García-Montoya
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.